<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39534771</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>A worldwide perspective of long COVID management: how can we END-COVID?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">00500-2024</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00500-2024</ELocationID><Abstract><AbstractText><b>A global survey revealed marked heterogeneity in long COVID management worldwide</b> https://bit.ly/4dVTJ2t.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Hayoung</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4812-0653</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1183/23120541.00096-2024</RefSource></CommentsCorrections></CommentsCorrectionsList><CoiStatement>Conflict of interest: The author declares no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39534771</ArticleId><ArticleId IdType="pmc">PMC11551858</ArticleId><ArticleId IdType="doi">10.1183/23120541.00500-2024</ArticleId><ArticleId IdType="pii">00500-2024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO COVID-19 dashboard. 2024. https://data.who.int/dashboards/covid19. Date last accessed: May 15, 2024.</Citation></Reference><Reference><Citation>Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (long COVID): a scoping review. Front Med (Lausanne) 2021; 8: 750378. doi:10.3389/fmed.2021.750378</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.750378</ArticleId><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2013;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. . Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis 2022; 226: 1593&#x2013;1607. doi:10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, et al. . Long COVID and significant activity limitation among adults, by age &#x2013; United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb Mortal Wkly Rep 2023; 72: 866&#x2013;870. doi:10.15585/mmwr.mm7232a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022; 22: e102&#x2013;e107. doi:10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigro M, Valenzuela C, Arancibia F, et al. . A worldwide look into long COVID-19 management: an END-COVID survey. ERJ Open Res 2024; 10: 00096-2024. doi:10.1183/23120541.00096-2024</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00096-2024</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, et al. . Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021; 372: n136. doi:10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Somerville LAL, List RP, Compton MH, et al. . Real-world outcomes in cystic fibrosis telemedicine clinical care in a time of a global pandemic. Chest 2022; 161: 1167&#x2013;1179. doi:10.1016/j.chest.2021.11.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.11.035</ArticleId><ArticleId IdType="pmc">PMC8660127</ArticleId><ArticleId IdType="pubmed">34896356</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaclyn D, Andrew N, Ryan P, et al. . Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19. J Cyst Fibros 2021; 20: e23&#x2013;e28. doi:10.1016/j.jcf.2021.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcf.2021.09.004</ArticleId><ArticleId IdType="pmc">PMC7997421</ArticleId><ArticleId IdType="pubmed">33775604</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al. . Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open 2022; 5: e2238804. doi:10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerayeli FV, Eddy R, Sin DD. A proposed approach to pulmonary long COVID: a viewpoint. Eur Respir J 2024; in press [10.1183/13993003.02302-2023].</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02302-2023</ArticleId><ArticleId IdType="pmc">PMC11391093</ArticleId><ArticleId IdType="pubmed">38453258</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>